Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Nov 1;171(11):1199-205.
doi: 10.1176/appi.ajp.2014.13050595.

Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm

Jed E Rose  1 , Frédérique M Behm
Affiliations
Randomized Controlled Trial

Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm

Jed E Rose et al. Am J Psychiatry. .

Abstract

Objective: The authors assessed the efficacy and safety of combination treatment with varenicline and sustained-release bupropion for smokers who, based on an assessment of initial smoking reduction prior to the quit date, were deemed unlikely to achieve abstinence using nicotine patch treatment.

Method: In a randomized, double-blind, parallel-group adaptive treatment trial, the authors identified 222 cigarette smokers who failed to show a reduction of more than 50% in smoking after 1 week of nicotine patch treatment. Smokers were randomly assigned to receive 12 weeks of varenicline plus bupropion or varenicline plus placebo. The primary outcome measure was continuous smoking abstinence at weeks 8-11 after the target quit date.

Results: Both treatments were well tolerated. Participants who received the combination treatment had a significantly higher abstinence rate than those who received varenicline plus placebo (39.8% compared with 25.9%; odds ratio=1.89; 95% CI=1.07, 3.35). Combination treatment had a significantly greater effect on abstinence rate in male smokers (odds ratio=4.26; 95% CI=1.73, 10.49) than in female smokers (odds ratio=0.94; 95% CI=0.43, 2.05). It also had a significantly greater effect in highly nicotine-dependent smokers (odds ratio=3.51, 95% CI=1.64, 7.51) than in smokers with lower levels of dependence (odds ratio=0.71, 95% CI=0.28, 1.80).

Conclusions: Among smokers who did not show a sufficient initial response to prequit nicotine patch treatment, combination treatment with varenicline and bupropion proved more efficacious than varenicline alone for male smokers and for smokers with a high degree of nicotine dependence.

Trial registration: ClinicalTrials.gov NCT01303861.

PubMed Disclaimer

Figures

Figure 1
Figure 1
CONSORT diagram depicting participant recruitment, eligibility assessment, allocation to treatment conditions, and disposition.
Figure 2
Figure 2
See this image and copyright information in PMC

Comment in

References

    1. Lando HA, Wilson K. Combating the global tobacco epidemic. Preventive medicine. 2010 Jan-Feb;50(1–2):11–2. - PubMed
    1. Thun MJ, Carter BD, Feskanich D, Freedman ND, Prentice R, Lopez AD, Hartge P, Gapstur SM. 50-year trends in smoking-related mortality in the United States. The New England Journal of Medicine. 2013 Jan 24;368(4):351–64. - PMC - PubMed
    1. Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, McAfee T, Peto R. 21st-century hazards of smoking and benefits of cessation in the United States. The New England journal of medicine. 2013 Jan 24;368(4):341–50. - PubMed
    1. Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA : the journal of the American Medical Association. 2006 Jul 5;296(1):47–55. - PubMed
    1. Lindson N, Aveyard P. Response to Rose (2011): nicotine preloading: the importance of a pre-cessation reduction in smoking behavior. Psychopharmacology. 2011 Nov;218(2):459–60. - PubMed

Publication types

MeSH terms

Associated data